Advertisement

Journal of General Internal Medicine

, Volume 33, Issue 7, pp 1192–1195 | Cite as

Vascular Ehlers-Danlos Syndrome Presenting as a Pulsatile Neck Mass: a Case Report and Review of Literature

  • Bharat Maraj
  • Emily Harding-Theobald
  • Fatima Karaki
Clinical Practice: Clinical Vignettes

Abstract

Ehlers-Danlos syndrome refers to a spectrum of connective tissue disorders typically caused by mutations in genes responsible for the synthesis of collagen. Patients with Ehlers-Danlos syndrome often exhibit hyperflexibility of joints, increased skin elasticity, and tissue fragility. Vascular Ehlers-Danlos (vEDS) is a subtype of Ehlers-Danlos syndrome with a predilection to involve blood vessels. As such, it often manifests as vascular aneurysms and vessel rupture leading to hemorrhage. There are few reports describing primary prevention of aneurysms in the setting of undiagnosed, suspected vEDS. We present a case of a 30-year-old woman who presents with a pulsatile neck mass found to have multiple arterial aneurysms on imaging, hyperflexibility, and characteristic facial features consistent with vEDS. As described in this case, management of a suspected connective tissue disorder is a multidisciplinary approach including vascular surgery, medical therapy, and genetic testing to confirm the diagnosis. We review literature regarding the care of patients with vascular Ehlers-Danlos as it might pertain to hospitalized patients.

KEY WORDS

vascular Ehlers-danlos aneurysm 

Notes

Compliance with Ethical Standards

Conflict of interest

The authors declare that they do not have a conflict of interest.

References

  1. 1.
    Germain DP, Herrera-Guzman Y. Vascular Ehlers-Danlos syndrome. Ann Genet 2004;47:1–9.CrossRefGoogle Scholar
  2. 2.
    Barabas AP. Heterogeneity of the Ehlers-Danlos syndrome. Description of clinical types and a hypothesis to explain the basic defect. BMJ 1967;2:612–3.CrossRefGoogle Scholar
  3. 3.
    Barabas AP. Vascular complications in the Ehlers-Danlos syndrome, with especial reference to the “arterial type” or Sack’s syndrome. J Cardiovasc Surg 1972;13:160.Google Scholar
  4. 4.
    Pope FM, Martin GR, Lichtenstein JR, et al. Patients with Ehlers-Danlos syndrome type IV lack type III collagen. Proc Natl Acad Sci 1975;72(4):1314–6.CrossRefGoogle Scholar
  5. 5.
    Oderich GS, Panneton JM, Bower TC, et al. The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV: a 30-year experience. J Vasc Surg. 2005;42(1):98–106.CrossRefGoogle Scholar
  6. 6.
    Kamiya K, Yoshizu A, Kashizaki F. Vascular-type Ehlers-Danlos syndrome incidentally diagnosed at surgical treatment for hemothorax; report of a case. Kyobu Geka. 2013;66(2):173–5.PubMedGoogle Scholar
  7. 7.
    Leistritz DF, Pepin MG, Schwarze U, et al. COL3A1 haploinsufficiency results in a variety of Ehlers-Danlos syndrome type IV with delayed onset of complications and longer life expectancy. Genet Med. 2011;13(8):717–22.CrossRefGoogle Scholar
  8. 8.
    Jørgensen A, Fagerheim T, Rand-Hendriksen S, et al. Vascular Ehlers-Danlos Syndrome in siblings with biallelic COL3A1 sequence variants and marked clinical variability in the extended family. Eur J Hum Genet. 2015;23(6):796–802.CrossRefGoogle Scholar
  9. 9.
    Pepin M, Byers P. Ehlers-Danlos Syndrome, Vascular Type. Gene Reviews. Initial Posting: September 2, 1999; Last Update: May 3, 2011.Google Scholar
  10. 10.
    Malfait F, Francomano C, Byers P, et al. The 2017 international classification of the Ehlers–Danlos syndromes. Am J Med Genet Part C Semin Med Genet. 2017;175C:8–26.Google Scholar
  11. 11.
    Beighton P, De Paepe A, Steinmann B, et al. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Am J Med Genet 1998;77:31–7CrossRefGoogle Scholar
  12. 12.
    Frank M, Says J, Denarié N, et al. Successful segmental thermal ablation of varicose saphenous veins in a patient with confirmed vascular Ehlers-Danlos syndrome. Phlebology. 2016;31(3):222–4.CrossRefGoogle Scholar
  13. 13.
    Inokuchi R, Kurata H, Endo K, et al. Vascular Ehlers-Danlos syndrome without the characteristic facial features: a case report. Medicine (Baltimore). 2014;93(28):e291.CrossRefGoogle Scholar
  14. 14.
    Smits-Engelsman B, Klerks M, Kirby A. Beighton score: A valid measure for generalized hypermobility in children. J Pediatr. 2011;158:119–123123:e111-114.Google Scholar
  15. 15.
    Oderich GS, Panneton JM, Bower TC et al. The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV: a 30-year experience. J Vasc Surg. 2005;42:98–106.CrossRefGoogle Scholar
  16. 16.
    Zilocchi M, Macedo T, Oderich G, et al. Vascular Ehlers-Danlos Syndrome: Imaging Findings. Am J Rad. 2007;189:712–719.Google Scholar
  17. 17.
    Bergqvist D, Björck M, Wanhainen A. Treatment of vascular Ehlers-Danlos syndrome: a systematic review. Annals of Surgery. 2013;258(2):257–261.CrossRefGoogle Scholar
  18. 18.
    Linfante I, Lin E, Knott E, et al. Endovascular repair of direct carotid-cavernous fistula in Ehlers-Danlos type IV. J Neurointerv Surg. 2015;7(1):e3.CrossRefGoogle Scholar
  19. 19.
    Iida Y, Obitsu Y, Komai H, et al. Successful coil embolization for rupture of the subclavian artery associated with Ehlers-Danlos syndrome type IV. J Vasc Surg. 2009;50(5):1191–5.CrossRefGoogle Scholar
  20. 20.
    Ong KT, Perdu J, De Backer J, et al. Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial. Lancet. 2010;376(9751):1476–84.CrossRefGoogle Scholar
  21. 21.
    Hugon-Rodin J, Lebegue G, Becourt S, et al. Gynecologic symptoms and the influence on reproductive life in 386 women with hypermobility type ehlers-danlos syndrome: a cohort study. Orphanet J Rare Dis. 2016;11(1):124.CrossRefGoogle Scholar
  22. 22.
    Shields LBE, Rolf CM, Davis GJ, et al. Sudden and unexpected death in three cases of Ehlers-Danlos syndrome type IV. J Forensic Sciences. 2010;55(6):1641–1645.CrossRefGoogle Scholar
  23. 23.
    Callewaert B, Malfait F, Loeys B, et al. Ehlers-Danlos syndrome and Marfan syndrome; Best Practice and Research. Clinical Rheumatology. 2008;22:165–189.CrossRefGoogle Scholar

Copyright information

© The Author(s) 2018

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors and Affiliations

  • Bharat Maraj
    • 1
  • Emily Harding-Theobald
    • 1
  • Fatima Karaki
    • 1
  1. 1.Department of Medicine University of California, San Francisco Medical CenterSan FranciscoUSA

Personalised recommendations